Company / FCF Margin
Foghorn Therapeutics Inc. FCF Margin History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-448.2%
FY2025
5-year range
-11039.3% / 1000.6%
FY2021-FY2025
Trend
-28.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from 1000.6% to -448.2% over the past 2 years.
Based on SEC 10-K filings.
-448.2% in FY2025 with a 5-year CAGR of +10552.5%.
Declined from 1000.6% to -448.2% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- +3612.6pp
- 5-Year Change
- +10552.5pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin decreased 28.3% year-over-year.
- Peak fcf margin was recorded in FY2023.
- Lowest fcf margin in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -1.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -448.2% | -28.3% |
| FY2024 | -349.4% | -134.9% |
| FY2023 | 1000.6% | +124.6% |
| FY2022 | -4060.9% | +63.2% |
| FY2021 | -11039.3% | -0.4% |
| FY2020 | -11000.7% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026